This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Sandostatin LAR Depot, octreotide acetate
Description: Sandostatin LAR Depot is a long-acting dosage form of Sandostatin using microspheres of a biodegradable polymer.
Deal Structure: BioMedTracker groups Sandostatin and Sandostatin LAR revenue together under Sandostatin LAR.
Sandostatin LAR News
Pink Sheet Novartis Sandostatin LAR
Additional information available to subscribers only: